240 related articles for article (PubMed ID: 20733112)
1. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Riddle MC
Circulation; 2010 Aug; 122(8):844-6. PubMed ID: 20733112
[No Abstract] [Full Text] [Related]
2. [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].
Lambiel J; Fumeaux T
Rev Med Suisse; 2008 Aug; 4(166):1734. PubMed ID: 18777740
[No Abstract] [Full Text] [Related]
3. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial--clinical implications.
Ismail-Beigi F
Clin Chem; 2011 Feb; 57(2):261-3. PubMed ID: 20974799
[No Abstract] [Full Text] [Related]
4. Diabetes. Insights from the extended follow-up of the ACCORD trial.
Zoungas S; Woodward M
Nat Rev Cardiol; 2011 Jun; 8(6):308-10. PubMed ID: 21502962
[TBL] [Abstract][Full Text] [Related]
5. Clinical research. Deaths in diabetes trial challenge a long-held theory.
Couzin J
Science; 2008 Feb; 319(5865):884-5. PubMed ID: 18276854
[No Abstract] [Full Text] [Related]
6. Intensive glucose control and cardiovascular disease in type 2 diabetes--should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials.
Gaede P
Pol Arch Med Wewn; 2008 Nov; 118(11):619-21. PubMed ID: 19140564
[No Abstract] [Full Text] [Related]
7. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.
Meier M; Hummel M
Vasc Health Risk Manag; 2009; 5():859-71. PubMed ID: 19898642
[TBL] [Abstract][Full Text] [Related]
8. Why are we doing cardiovascular outcome trials in type 2 diabetes?
Menon V; Aggarwal B
Cleve Clin J Med; 2014 Nov; 81(11):665-71. PubMed ID: 25368216
[TBL] [Abstract][Full Text] [Related]
9. [Acute blood sugar peaks endanger blood vessels: the postprandial situation to be controlled better].
MMW Fortschr Med; 2006 Jun; 148(26):57. PubMed ID: 16875385
[No Abstract] [Full Text] [Related]
10. Diabetes control among Hispanics in the action to control cardiovascular risk in diabetes trial.
Getaneh A; Light LS; Brillon DJ; Calles Escandón J; Felicetta J; Evans GW; Lopez-Jimenez CR; Cuddihy R; Bigger JT
J Gen Intern Med; 2012 Nov; 27(11):1499-505. PubMed ID: 22744725
[TBL] [Abstract][Full Text] [Related]
11. Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials.
Riddle MC; Karl DM
Diabetes Care; 2012 Oct; 35(10):2100-7. PubMed ID: 22996182
[No Abstract] [Full Text] [Related]
12. Intensive glycemic control and cardiovascular disease: an update.
Brown A; Reynolds LR; Bruemmer D
Nat Rev Cardiol; 2010 Jul; 7(7):369-75. PubMed ID: 20404853
[TBL] [Abstract][Full Text] [Related]
13. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
Füchtenbusch M; Hummel M
MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
[No Abstract] [Full Text] [Related]
14. [Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials].
Radermecker RP; Philips JC; Jandrain B; Paquot N; Scheen AJ
Rev Med Liege; 2008; 63(7-8):511-8. PubMed ID: 18771232
[TBL] [Abstract][Full Text] [Related]
15. [Intensive glucose control in type 2 diabetes is beneficial].
Nilsson PM; Attvall S
Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
[No Abstract] [Full Text] [Related]
16. Diabetes. Paradoxical effects of tightly controlled blood sugar.
Taubes G
Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
[No Abstract] [Full Text] [Related]
17. Control of cardiovascular risk factors in the Veterans Affairs Diabetes Trial in advanced type 2 diabetes.
Duckworth WC; McCarren M; Abraira C;
Endocr Pract; 2006; 12 Suppl 1():85-8. PubMed ID: 16627388
[TBL] [Abstract][Full Text] [Related]
18. [Certain beginning of insulin therapy: yes, we can, but...].
Rohrer A
Praxis (Bern 1994); 2009 Mar; 98(6):301. PubMed ID: 19338117
[No Abstract] [Full Text] [Related]
19. [Comment from the diabetology viewpoint].
Stahl M
Praxis (Bern 1994); 2008 Aug; 97(17):943-4. PubMed ID: 18777777
[No Abstract] [Full Text] [Related]
20. What matters in ADVANCE and ADVANCE-ON.
Hamet P
Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():20-9. PubMed ID: 22118707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
